| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL22A1 COL1A2 | 4.54e-16 | 46 | 69 | 10 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL22A1 COL1A2 | 9.05e-10 | 188 | 69 | 10 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 MATR3 COL5A3 COL22A1 BSN COL1A2 | 4.88e-05 | 891 | 69 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | SMAD binding | 2.24e-04 | 86 | 69 | 4 | GO:0046332 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 7.60e-04 | 12 | 69 | 2 | GO:0048407 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL22A1 MMP1 COL1A2 | 3.97e-08 | 377 | 68 | 11 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL22A1 MMP1 COL1A2 | 4.08e-08 | 378 | 68 | 11 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL22A1 MMP1 COL1A2 | 4.19e-08 | 379 | 68 | 11 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen fibril organization | 1.16e-04 | 76 | 68 | 4 | GO:0030199 | |
| GeneOntologyBiologicalProcess | aorta development | 1.41e-04 | 80 | 68 | 4 | GO:0035904 | |
| GeneOntologyCellularComponent | collagen trimer | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 COL20A1 WDR33 C1QTNF9 C1QTNF9B COL5A3 C1QTNF3 COL22A1 COL1A2 | 3.69e-24 | 88 | 69 | 16 | GO:0005581 |
| GeneOntologyCellularComponent | complex of collagen trimers | 5.40e-11 | 21 | 69 | 6 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.10e-08 | 332 | 69 | 11 | GO:0005788 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.27e-08 | 12 | 69 | 4 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.27e-08 | 12 | 69 | 4 | GO:0098643 | |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 ZAN COL20A1 COL5A3 COL22A1 MMP1 COL1A2 | 1.95e-07 | 656 | 69 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 ZAN COL20A1 COL5A3 COL22A1 MMP1 COL1A2 | 2.02e-07 | 658 | 69 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.21e-06 | 530 | 69 | 11 | GO:0062023 |
| GeneOntologyCellularComponent | collagen type V trimer | 6.42e-05 | 4 | 69 | 2 | GO:0005588 | |
| GeneOntologyCellularComponent | mRNA cleavage and polyadenylation specificity factor complex | 8.47e-05 | 26 | 69 | 3 | GO:0005847 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.45e-04 | 31 | 69 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 2.97e-04 | 8 | 69 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 2.97e-04 | 8 | 69 | 2 | GO:0098645 | |
| HumanPheno | Atrophic scars | 7.31e-07 | 37 | 25 | 5 | HP:0001075 | |
| HumanPheno | Fragile skin | 7.31e-07 | 37 | 25 | 5 | HP:0001030 | |
| HumanPheno | Arterial rupture | 5.76e-06 | 8 | 25 | 3 | HP:0025019 | |
| HumanPheno | Osteoarthritis | 1.26e-05 | 65 | 25 | 5 | HP:0002758 | |
| HumanPheno | Atypical scarring of skin | 2.39e-05 | 74 | 25 | 5 | HP:0000987 | |
| HumanPheno | Hypermobility of distal interphalangeal joints | 6.92e-05 | 3 | 25 | 2 | HP:0006201 | |
| HumanPheno | Scarring | 1.13e-04 | 102 | 25 | 5 | HP:0100699 | |
| HumanPheno | Hip dysplasia | 1.31e-04 | 247 | 25 | 7 | HP:0001385 | |
| HumanPheno | Cervical insufficiency | 1.38e-04 | 4 | 25 | 2 | HP:0030009 | |
| HumanPheno | Genital blistering | 1.38e-04 | 4 | 25 | 2 | HP:0031464 | |
| HumanPheno | Dermal atrophy | 1.42e-04 | 107 | 25 | 5 | HP:0004334 | |
| HumanPheno | Hypermobility of interphalangeal joints | 2.29e-04 | 5 | 25 | 2 | HP:0005620 | |
| HumanPheno | Coxa vara | 2.97e-04 | 68 | 25 | 4 | HP:0002812 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 3.31e-04 | 201 | 25 | 6 | HP:0008065 | |
| Domain | Collagen | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 COL20A1 WDR33 C1QTNF9 C1QTNF9B COL5A3 C1QTNF3 COL22A1 COL1A2 | 1.55e-23 | 85 | 70 | 16 | IPR008160 |
| Domain | Collagen | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 COL20A1 WDR33 C1QTNF9 C1QTNF9B COL5A3 C1QTNF3 COL22A1 COL1A2 | 1.55e-23 | 85 | 70 | 16 | PF01391 |
| Domain | Fib_collagen_C | 2.90e-10 | 11 | 70 | 5 | IPR000885 | |
| Domain | COLFI | 2.90e-10 | 11 | 70 | 5 | PF01410 | |
| Domain | NC1_FIB | 2.90e-10 | 11 | 70 | 5 | PS51461 | |
| Domain | Fib_collagen_C | 2.90e-10 | 11 | 70 | 5 | PD002078 | |
| Domain | COLFI | 2.90e-10 | 11 | 70 | 5 | SM00038 | |
| Domain | TSPN | 1.52e-06 | 23 | 70 | 4 | SM00210 | |
| Domain | C1Q | 6.01e-06 | 32 | 70 | 4 | SM00110 | |
| Domain | C1q | 6.01e-06 | 32 | 70 | 4 | PF00386 | |
| Domain | C1q_dom | 7.71e-06 | 34 | 70 | 4 | IPR001073 | |
| Domain | C1Q | 7.71e-06 | 34 | 70 | 4 | PS50871 | |
| Domain | - | 3.66e-05 | 50 | 70 | 4 | 2.60.120.40 | |
| Domain | Laminin_G | 6.59e-05 | 58 | 70 | 4 | IPR001791 | |
| Domain | Tumour_necrosis_fac-like_dom | 6.59e-05 | 58 | 70 | 4 | IPR008983 | |
| Domain | ConA-like_dom | 1.70e-04 | 219 | 70 | 6 | IPR013320 | |
| Domain | VWFC_1 | 3.29e-04 | 36 | 70 | 3 | PS01208 | |
| Domain | VWC | 3.87e-04 | 38 | 70 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.87e-04 | 38 | 70 | 3 | PS50184 | |
| Domain | VWF_dom | 5.21e-04 | 42 | 70 | 3 | IPR001007 | |
| Domain | - | 2.70e-03 | 74 | 70 | 3 | 3.40.50.410 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 3.89e-18 | 44 | 52 | 11 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.92e-16 | 41 | 52 | 10 | MM15538 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 6.13e-16 | 67 | 52 | 11 | M26999 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.46e-14 | 61 | 52 | 10 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.87e-14 | 90 | 52 | 11 | M631 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.48e-13 | 76 | 52 | 10 | MM14573 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL5A3 COL1A2 | 9.15e-13 | 61 | 52 | 9 | M27103 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL5A3 MMP1 COL1A2 | 1.44e-12 | 64 | 52 | 9 | M26953 |
| Pathway | PID_SYNDECAN_1_PATHWAY | 2.93e-10 | 46 | 52 | 7 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.41e-10 | 50 | 52 | 7 | MM14796 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 MMP1 COL1A2 | 6.69e-10 | 300 | 52 | 12 | M610 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.27e-10 | 53 | 52 | 7 | MM14566 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.58e-09 | 32 | 52 | 6 | MM14924 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL5A3 MMP1 COL1A2 | 1.86e-09 | 140 | 52 | 9 | M587 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL3A1 COL4A2 COL5A2 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 MMP1 COL1A2 | 1.94e-09 | 258 | 52 | 11 | MM14572 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 8.34e-09 | 20 | 52 | 5 | MM15061 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 2.42e-08 | 85 | 52 | 7 | M16441 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.26e-08 | 59 | 52 | 6 | M27218 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.45e-08 | 30 | 52 | 5 | M27772 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.86e-07 | 114 | 52 | 7 | MM14571 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.57e-07 | 38 | 52 | 5 | MM14969 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 2.86e-07 | 74 | 52 | 6 | M160 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 3.36e-07 | 76 | 52 | 6 | M27219 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.36e-07 | 76 | 52 | 6 | MM14867 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.80e-07 | 41 | 52 | 5 | M27778 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 4.30e-07 | 42 | 52 | 5 | M7169 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 4.85e-07 | 43 | 52 | 5 | M39565 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.12e-07 | 19 | 52 | 4 | MM15512 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.65e-07 | 47 | 52 | 5 | MM14925 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.03e-06 | 57 | 52 | 5 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 2.22e-06 | 58 | 52 | 5 | M2049 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.71e-06 | 27 | 52 | 4 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 3.16e-06 | 28 | 52 | 4 | MM15957 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.35e-06 | 63 | 52 | 5 | M11187 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.20e-06 | 30 | 52 | 4 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.03e-05 | 79 | 52 | 5 | M27643 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.39e-05 | 84 | 52 | 5 | M7098 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 4.40e-05 | 19 | 52 | 3 | M27221 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.06e-04 | 67 | 52 | 4 | MM15345 | |
| Pathway | WP_13Q1212_COPY_NUMBER_VARIATION | 2.61e-04 | 34 | 52 | 3 | M48103 | |
| Pathway | PID_FRA_PATHWAY | 3.37e-04 | 37 | 52 | 3 | M65 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.65e-04 | 38 | 52 | 3 | MM15456 | |
| Pathway | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | 3.94e-04 | 39 | 52 | 3 | M10735 | |
| Pathway | WP_FOCAL_ADHESION | 6.11e-04 | 187 | 52 | 5 | MM15913 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.79e-04 | 532 | 52 | 8 | M27870 | |
| Pathway | WP_FOCAL_ADHESION | 8.09e-04 | 199 | 52 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.09e-04 | 199 | 52 | 5 | M7253 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.36e-03 | 15 | 52 | 2 | M27161 | |
| Pathway | PID_ENDOTHELIN_PATHWAY | 1.61e-03 | 63 | 52 | 3 | M8 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.84e-03 | 66 | 52 | 3 | M18 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.97e-03 | 18 | 52 | 2 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 1.97e-03 | 18 | 52 | 2 | MM14882 | |
| Pathway | PID_AP1_PATHWAY | 2.18e-03 | 70 | 52 | 3 | M167 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 2.43e-03 | 20 | 52 | 2 | M497 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 2.43e-03 | 20 | 52 | 2 | MM15469 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.68e-03 | 261 | 52 | 5 | MM15676 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.21e-03 | 418 | 52 | 6 | MM15587 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | 4.43e-11 | 62 | 70 | 7 | 28344315 | |
| Pubmed | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL5A3 COL22A1 COL1A2 | 8.40e-11 | 175 | 70 | 9 | 28071719 | |
| Pubmed | 8.74e-10 | 153 | 70 | 8 | 25037231 | ||
| Pubmed | 1.47e-09 | 25 | 70 | 5 | 19180518 | ||
| Pubmed | Collagen II is essential for the removal of the notochord and the formation of intervertebral discs. | 2.02e-08 | 15 | 70 | 4 | 9832566 | |
| Pubmed | 2.69e-08 | 16 | 70 | 4 | 17881772 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 12874293 | ||
| Pubmed | 4.82e-08 | 167 | 70 | 7 | 22159717 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 10722718 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 8305476 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 9101290 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.27e-07 | 135 | 70 | 6 | 28675934 | |
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 15872058 | ||
| Pubmed | 3D Mapping Reveals a Complex and Transient Interstitial Matrix During Murine Kidney Development. | 4.34e-07 | 8 | 70 | 3 | 33875569 | |
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 9164858 | ||
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 18816857 | ||
| Pubmed | Collagen XXVII organises the pericellular matrix in the growth plate. | 6.50e-07 | 9 | 70 | 3 | 22206015 | |
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 14559231 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.59e-06 | 97 | 70 | 5 | 27559042 | |
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 18783346 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 16236725 | ||
| Pubmed | 3.23e-06 | 50 | 70 | 4 | 23658023 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35964930 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24030394 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16681691 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 36766785 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 37945738 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22514273 | ||
| Pubmed | A role for Tbx2 in the regulation of the alpha2(1) collagen gene in human fibroblasts. | 3.99e-06 | 2 | 70 | 2 | 17407139 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 38741428 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25783894 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21836066 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31182031 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30764693 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29145717 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24473438 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22972916 | ||
| Pubmed | Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. | 3.99e-06 | 2 | 70 | 2 | 3858826 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27188183 | ||
| Pubmed | Ablation of Ctrp9, Ligand of AdipoR1, and Lower Number of Cone Photoreceptors in Mouse Retina. | 3.99e-06 | 2 | 70 | 2 | 35575905 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30426302 | ||
| Pubmed | CTRP9 ameliorates cellular senescence via PGC‑1α/AMPK signaling in mesenchymal stem cells. | 3.99e-06 | 2 | 70 | 2 | 29749459 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26419929 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 31903873 | ||
| Pubmed | CTRP9 induces iNOS expression through JAK2/STAT3 pathway in Raw 264.7 and peritoneal macrophages. | 3.99e-06 | 2 | 70 | 2 | 31837806 | |
| Pubmed | Specific hybridization probes for mouse alpha 2(IX) and alpha 1(X) collagen mRNAs. | 3.99e-06 | 2 | 70 | 2 | 1543751 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28978553 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32831639 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2981217 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32283037 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7825727 | ||
| Pubmed | CTRP9 Promotes Brown Adipose Tissue Lipolysis in Mice Fed a High-Fat Diet. | 3.99e-06 | 2 | 70 | 2 | 38940054 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28367737 | ||
| Pubmed | C1q-TNF-Related Protein-9 Promotes Cardiac Hypertrophy and Failure. | 3.99e-06 | 2 | 70 | 2 | 27821723 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26754066 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19398000 | ||
| Pubmed | CTRP9 alleviates foam cells apoptosis by enhancing cholesterol efflux. | 3.99e-06 | 2 | 70 | 2 | 33352225 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11566270 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 35008006 | ||
| Pubmed | 4.29e-06 | 210 | 70 | 6 | 16537572 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L STOX2 MEGF8 MATR3 SEC24B SEC16A MAP3K10 CEP152 NCKAP5L PPP1R12C | 8.51e-06 | 861 | 70 | 10 | 36931259 |
| Pubmed | Molecular mechanism of type I collagen homotrimer resistance to mammalian collagenases. | 1.20e-05 | 3 | 70 | 2 | 20463013 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 31930700 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 35115674 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 20039537 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34205850 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 37158802 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 25870106 | ||
| Pubmed | Isolation of the alpha 3-chain of human type V collagen and characterization by partial sequencing. | 1.20e-05 | 3 | 70 | 2 | 1571108 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 17146610 | ||
| Pubmed | Coordinate patterns of expression of type I and III collagens during mouse development. | 1.20e-05 | 3 | 70 | 2 | 8785585 | |
| Pubmed | Biosynthetic processing of the Pro-alpha1(V)Pro-alpha2(V)Pro-alpha3(V) procollagen heterotrimer. | 1.20e-05 | 3 | 70 | 2 | 15136578 | |
| Pubmed | Differential expression of type I and type III collagen genes during tooth development. | 1.20e-05 | 3 | 70 | 2 | 1879336 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24641356 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 22788708 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 30557342 | ||
| Pubmed | CTRP9 transgenic mice are protected from diet-induced obesity and metabolic dysfunction. | 1.20e-05 | 3 | 70 | 2 | 23842676 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 30978318 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 6501291 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 29925877 | ||
| Pubmed | CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages. | 1.20e-05 | 3 | 70 | 2 | 25701788 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 7346227 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 10390159 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 17662583 | ||
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 1.20e-05 | 3 | 70 | 2 | 1297453 | |
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.27e-05 | 254 | 70 | 6 | 28431233 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | ATXN2L WDR33 TNIP2 MATR3 SEC24B SEC16A CSTF2 YBX3 NCKAP5L BAG6 | 1.54e-05 | 922 | 70 | 10 | 27609421 |
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 2.21e-05 | 27 | 70 | 3 | 12192060 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 18787108 | ||
| Pubmed | Localization of types I and III collagen and fibronectin in the developing mouse palatal shelves. | 2.39e-05 | 4 | 70 | 2 | 8984825 | |
| Pubmed | CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members. | 2.39e-05 | 4 | 70 | 2 | 19666007 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 19836620 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 10580848 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 19932771 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 24361166 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 33502806 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 29263043 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 38348774 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 1409674 | ||
| Pubmed | Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. | 2.39e-05 | 4 | 70 | 2 | 18323784 | |
| Interaction | COLGALT2 interactions | 1.00e-07 | 67 | 68 | 6 | int:COLGALT2 | |
| Interaction | COL4A2 interactions | 5.41e-06 | 75 | 68 | 5 | int:COL4A2 | |
| Interaction | COL1A2 interactions | 6.57e-06 | 78 | 68 | 5 | int:COL1A2 | |
| Interaction | MIR19A interactions | 2.21e-05 | 100 | 68 | 5 | int:MIR19A | |
| Interaction | LAIR2 interactions | 2.24e-05 | 49 | 68 | 4 | int:LAIR2 | |
| Interaction | COL12A1 interactions | 2.43e-05 | 50 | 68 | 4 | int:COL12A1 | |
| Interaction | MIR34B interactions | 3.51e-05 | 110 | 68 | 5 | int:MIR34B | |
| Interaction | P4HA1 interactions | 6.46e-05 | 298 | 68 | 7 | int:P4HA1 | |
| Interaction | COL2A1 interactions | 6.47e-05 | 64 | 68 | 4 | int:COL2A1 | |
| Interaction | COL5A1 interactions | 6.87e-05 | 65 | 68 | 4 | int:COL5A1 | |
| Interaction | COL5A2 interactions | 1.26e-04 | 29 | 68 | 3 | int:COL5A2 | |
| Interaction | MAG interactions | 1.26e-04 | 29 | 68 | 3 | int:MAG | |
| GeneFamily | Collagens | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 2.16e-19 | 46 | 49 | 11 | 490 |
| GeneFamily | Endogenous ligands|C1q and TNF related | 1.48e-05 | 18 | 49 | 3 | 1372 | |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.16e-19 | 43 | 70 | 11 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 1.55e-19 | 44 | 70 | 11 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 7.00e-12 | 270 | 70 | 12 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 COL20A1 COL5A3 COL22A1 COL1A2 | 8.67e-12 | 275 | 70 | 12 | M5884 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 MEGF8 COL20A1 C1QTNF9 C1QTNF9B COL5A3 C1QTNF3 COL22A1 MMP1 COL1A2 | 8.89e-10 | 1008 | 70 | 17 | MM17056 |
| Coexpression | NABA_MATRISOME | COL3A1 COL4A2 COL5A2 COL24A1 COL9A2 COL10A1 GLDN COL17A1 MEGF8 COL20A1 C1QTNF9 C1QTNF9B COL5A3 C1QTNF3 COL22A1 MMP1 COL1A2 | 1.16e-09 | 1026 | 70 | 17 | M5889 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR | 2.69e-07 | 99 | 70 | 6 | M39152 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 4.82e-07 | 58 | 70 | 5 | M178 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 7.93e-07 | 64 | 70 | 5 | M2572 | |
| Coexpression | GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 1.08e-06 | 200 | 70 | 7 | M9675 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 1.64e-06 | 74 | 70 | 5 | M13547 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 4.47e-06 | 352 | 70 | 8 | M17471 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | COL3A1 FZD1 BOC COL4A2 COL5A2 GLDN TENM4 HOXD4 NBL1 COL5A3 COL1A2 | 5.63e-06 | 767 | 70 | 11 | M39209 |
| Coexpression | VANHARANTA_UTERINE_FIBROID_UP | 5.84e-06 | 44 | 70 | 4 | M18274 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP | 7.63e-06 | 47 | 70 | 4 | M7585 | |
| Coexpression | ROY_WOUND_BLOOD_VESSEL_UP | 9.79e-06 | 50 | 70 | 4 | M7337 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.60e-05 | 200 | 70 | 6 | M5930 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 1.71e-05 | 19 | 70 | 3 | M15125 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 1.76e-05 | 120 | 70 | 5 | M42505 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.23e-05 | 126 | 70 | 5 | M39132 | |
| Coexpression | TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP | 4.66e-05 | 74 | 70 | 4 | M4479 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 4.99e-05 | 149 | 70 | 5 | M45703 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 5.95e-05 | 505 | 70 | 8 | M39167 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 6.34e-05 | 29 | 70 | 3 | MM17055 | |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 6.64e-05 | 81 | 70 | 4 | M39253 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | COL3A1 COL4A2 BEX3 COL5A2 COL10A1 ARHGEF40 RRP1B ALKBH2 CEP152 COL22A1 MMP1 NUP42 COL1A2 | 7.87e-05 | 1407 | 70 | 13 | M14427 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.12e-04 | 35 | 70 | 3 | M11788 | |
| Coexpression | WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN | 1.14e-04 | 93 | 70 | 4 | M4752 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 1.22e-04 | 36 | 70 | 3 | MM1212 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 1.65e-04 | 192 | 70 | 5 | M42501 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 1.90e-04 | 198 | 70 | 5 | MM17083 | |
| Coexpression | GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN | 1.95e-04 | 199 | 70 | 5 | M3479 | |
| Coexpression | GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP | 1.99e-04 | 200 | 70 | 5 | M9608 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.89e-04 | 479 | 70 | 7 | M2573 | |
| Coexpression | CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL | 2.89e-04 | 48 | 70 | 3 | M39318 | |
| Coexpression | ZHU_CMV_ALL_DN | 2.94e-04 | 119 | 70 | 4 | M14555 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 3.04e-04 | 483 | 70 | 7 | MM1082 | |
| Coexpression | LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE | 3.08e-04 | 49 | 70 | 3 | M2899 | |
| Coexpression | RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP | 3.54e-04 | 125 | 70 | 4 | M15672 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 3.81e-04 | 11 | 70 | 2 | M47997 | |
| Coexpression | HOSHIDA_LIVER_CANCER_SUBCLASS_S1 | 4.18e-04 | 235 | 70 | 5 | M5311 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 4.55e-04 | 681 | 70 | 8 | M39175 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 4.56e-04 | 12 | 70 | 2 | M47985 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 4.68e-04 | 519 | 70 | 7 | M3395 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 5.01e-04 | 137 | 70 | 4 | M40313 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 5.33e-04 | 59 | 70 | 3 | M47989 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | FZD1 BOC COL5A2 ARHGEF40 TENM4 ATN1 ARHGAP31 ALKBH2 RTN4R SEC16A KLF14 NBL1 LYL1 NCKAP5L APBB1IP COL1A2 | 1.19e-06 | 1208 | 69 | 16 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_100 | 1.77e-05 | 99 | 69 | 5 | PCBC_ctl_CardiacMyocyte_100 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 2.01e-05 | 591 | 69 | 10 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#1 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 TNIP2 MARCHF4 APBB1IP TBX2 COL1A2 | 2.33e-05 | 878 | 69 | 12 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#5 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 1.13e-04 | 726 | 69 | 10 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.18e-04 | 589 | 69 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_2500_k-means-cluster#4 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 1.19e-04 | 731 | 69 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 1.23e-04 | 734 | 69 | 10 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL3A1 FZD1 BOC COL4A2 COL5A2 COL9A2 TENM4 HOXD4 COL5A3 MMP1 TBX2 COL1A2 | 1.91e-04 | 1094 | 69 | 12 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.24e-04 | 642 | 69 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_2500_k-means-cluster#2 | 2.51e-04 | 652 | 69 | 9 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_2500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#2 | COL3A1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 2.60e-04 | 655 | 69 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | COL3A1 COL24A1 COL9A2 COL17A1 CARMIL3 TRIM56 KLF14 SYNE4 APBB1IP TBX2 COL1A2 | 2.67e-04 | 967 | 69 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_100 | 3.05e-04 | 99 | 69 | 4 | PCBC_ctl_BronchSmoothMuscl_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | COL3A1 FZD1 BOC COL5A2 COL24A1 COL9A2 COL17A1 MARCHF4 TBX2 COL1A2 | 3.45e-04 | 834 | 69 | 10 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.59e-04 | 290 | 69 | 6 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000_K2 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.05e-10 | 188 | 70 | 8 | b382d18fb09fb2869f3c151efa71540a7f5ed229 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.58e-10 | 190 | 70 | 8 | 947807863a9b247c301c6cf63d6fd5a2c8018e66 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-10 | 191 | 70 | 8 | db4943dd19207663fb9e27f8940fa4b06a933625 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 6.86e-10 | 191 | 70 | 8 | aa43b472bc8362f79ae63f09f1ca764718bbf22c | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 7.45e-10 | 193 | 70 | 8 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.76e-10 | 194 | 70 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.09e-10 | 195 | 70 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.77e-10 | 197 | 70 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.12e-10 | 198 | 70 | 8 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.88e-10 | 200 | 70 | 8 | b441b3771fb7d9ee7b7a104afc35e466aace2da2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.88e-10 | 200 | 70 | 8 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.88e-10 | 200 | 70 | 8 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.88e-10 | 200 | 70 | 8 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.49e-09 | 157 | 70 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-09 | 167 | 70 | 7 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-09 | 167 | 70 | 7 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.42e-09 | 167 | 70 | 7 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.92e-09 | 171 | 70 | 7 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.08e-08 | 173 | 70 | 7 | fd6653d6be9ca6ac36798590694efe03cb758c67 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-08 | 180 | 70 | 7 | 935c091bbcd6d10b81dc4731779e5bd98205c99f | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.41e-08 | 180 | 70 | 7 | 3dd384b7f3d9582b8fec9fe05100e466e6218b76 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-08 | 181 | 70 | 7 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.47e-08 | 181 | 70 | 7 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NK|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.53e-08 | 182 | 70 | 7 | fb503f8ecd013f1f2161a5841572b57cfcddb6fa | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-08 | 183 | 70 | 7 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-08 | 183 | 70 | 7 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-08 | 183 | 70 | 7 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-08 | 187 | 70 | 7 | 150023e6a50c9da461f2321074d2d5e96caafb06 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.84e-08 | 187 | 70 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.91e-08 | 188 | 70 | 7 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 1.98e-08 | 189 | 70 | 7 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-08 | 191 | 70 | 7 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-08 | 191 | 70 | 7 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 192 | 70 | 7 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2-SCMF|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.21e-08 | 192 | 70 | 7 | 67e845e513e76e820f55e2f0d15eb16f2944d05c | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-08 | 192 | 70 | 7 | eeab1cef7c36ae824381952c5b2c982368c379fd | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.21e-08 | 192 | 70 | 7 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-08 | 193 | 70 | 7 | 59b8186d0221fba06a16157e9d148399ed801f38 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-08 | 193 | 70 | 7 | dc92680b4bb9fc26430c92e03adb839c8c3b3b98 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-08 | 193 | 70 | 7 | 03678162648bd5b1d65a5450b60c8863edbf95c7 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.29e-08 | 193 | 70 | 7 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-08 | 194 | 70 | 7 | 8fae8061b350336299aa81f378e07deadbd55123 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.37e-08 | 194 | 70 | 7 | 4d7d24390fdb379f943ddcc70a63f23955e10163 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-08 | 195 | 70 | 7 | b0d408f8bc1701a87596ed55efcd90749fee33e6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.45e-08 | 195 | 70 | 7 | a486a7acea0e91048cc48afa0dbd3926d30bc217 | |
| ToppCell | PCW_07-8.5-Mesenchymal|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.54e-08 | 196 | 70 | 7 | 8e10802f52e5e1853ea4ad34bf9a32a34e6112b5 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-08 | 196 | 70 | 7 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.54e-08 | 196 | 70 | 7 | 275e153347caf94edc0c50021bbab49c8696fecb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.63e-08 | 197 | 70 | 7 | 236a40eb6c08e1d179cf0fb5450b032975c5f6b6 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.63e-08 | 197 | 70 | 7 | 3fe665c0277d091290b63f0dd24c0c6536a45309 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.63e-08 | 197 | 70 | 7 | 16758f181ef07c60aee63072e1da9572c5c85414 | |
| ToppCell | (2)_Fibroblasts-(24)_Fibro-5|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.63e-08 | 197 | 70 | 7 | 83a4b79fbfa1cf63441dee4424c3b87c988287bf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.63e-08 | 197 | 70 | 7 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.73e-08 | 198 | 70 | 7 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-08 | 198 | 70 | 7 | 7582ee9ec8a87ecb094201f1f9191b412f9d2875 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-08 | 198 | 70 | 7 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.73e-08 | 198 | 70 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-08 | 199 | 70 | 7 | 84545ced0c792bc77980a50d65e484eab648d47e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-08 | 199 | 70 | 7 | 36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.82e-08 | 199 | 70 | 7 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 2.82e-08 | 199 | 70 | 7 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.82e-08 | 199 | 70 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.82e-08 | 199 | 70 | 7 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.82e-08 | 199 | 70 | 7 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | ILEUM-non-inflamed-(8)_Smooth_muscle_cells|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.82e-08 | 199 | 70 | 7 | 3368c0a90a47c4dcdfe70be3192550df0744e508 | |
| ToppCell | ILEUM-non-inflamed-(8)_Fibroblast|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.82e-08 | 199 | 70 | 7 | 6a0df9a2f30480043f9c1d7fbdede17eb0910cac | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.92e-08 | 200 | 70 | 7 | 01522ed0b68614b1ebdf190957d44a9d48a6c6e3 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-4|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.92e-08 | 200 | 70 | 7 | 7642a14855589b0b3f68dbdc9e4d3fc7291854f7 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.92e-08 | 200 | 70 | 7 | 954fee8425673e76198be414f5f6c4e3597c1919 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-08 | 200 | 70 | 7 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.92e-08 | 200 | 70 | 7 | 4f7e26b27bd51c32420ed8c2f52d070aee542159 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-08 | 200 | 70 | 7 | 444c72334df421375ae6fc69b0adfd4950d49a43 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-4|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.92e-08 | 200 | 70 | 7 | 5826c17da67bdaba3a828792279004218d8260c8 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-08 | 200 | 70 | 7 | 3c898e81444b001835c3f1bbc68183078701b135 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-08 | 200 | 70 | 7 | a603e8a999612d523bbce9d0feca9296d4a24c97 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_myofibroblast|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-08 | 200 | 70 | 7 | 251fd2923f108cd2086961d897244b392c32ad54 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.92e-08 | 200 | 70 | 7 | 0655328373d1b58828e141ddb0dcbb2cce10dc50 | |
| ToppCell | tumor_Lung-Fibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.92e-08 | 200 | 70 | 7 | 073a68b5ce232203ffee86342cba2a00d907e119 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.92e-08 | 200 | 70 | 7 | 3eca8ffeb41b664fbdbbd70b375c5d953503ab29 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-08 | 200 | 70 | 7 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.92e-08 | 200 | 70 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.09e-07 | 73 | 70 | 5 | 116259a036373bccaeb77fe3c675741a5ca81c52 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-07 | 158 | 70 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 2.31e-07 | 164 | 70 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.40e-07 | 165 | 70 | 6 | 4e13fccd32029e2879e85f8966e582a46c09e4aa | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-07 | 169 | 70 | 6 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-07 | 169 | 70 | 6 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-07 | 170 | 70 | 6 | 8465c3069bbc08705d070927e712b6bc85ac7c5b | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.06e-07 | 172 | 70 | 6 | 858cee96c1c06160863b4adcd7023c0d678bd50f | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-07 | 173 | 70 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | Control-Stromal-Pericyte|Control / Disease state, Lineage and Cell class | 3.28e-07 | 174 | 70 | 6 | 91fc1f1c891f105a91968c22e2de5321c52b439a | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.39e-07 | 175 | 70 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-Pericytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 3.50e-07 | 176 | 70 | 6 | 2015539c58aa0bb118e111ffedd63dd9fe863bb1 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-07 | 176 | 70 | 6 | 135d51d28a7ad2a67d5a6c49eb6e661f4beb66f5 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.50e-07 | 176 | 70 | 6 | 2287bd8382f41e36ebb0875a0133bada1ec81fa7 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-07 | 178 | 70 | 6 | a493a277d175e5e153410a745b26ebe2e0839ea0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-07 | 178 | 70 | 6 | 371218babddfd3d8a7bb82a46ce65327ee3fcf12 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.87e-07 | 179 | 70 | 6 | dcd0a83f0592ae27f814d064b4791f84c3c86e64 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-07 | 179 | 70 | 6 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-07 | 179 | 70 | 6 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| Computational | Neighborhood of PTX3 | 5.78e-06 | 36 | 36 | 4 | GNF2_PTX3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.19e-05 | 50 | 36 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Neighborhood of CDH11 | 7.54e-05 | 25 | 36 | 3 | GNF2_CDH11 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.07e-04 | 50 | 36 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | ECM and collagens. | 8.53e-04 | 225 | 36 | 5 | MODULE_47 | |
| Drug | d-indobufen | 2.27e-12 | 50 | 69 | 8 | CID000044562 | |
| Drug | GK-101 | 1.34e-11 | 36 | 69 | 7 | CID000161853 | |
| Drug | AC1LAKND | 1.39e-11 | 62 | 69 | 8 | CID000470146 | |
| Drug | BAPN | 4.28e-11 | 71 | 69 | 8 | CID000001647 | |
| Drug | Madecassol | 8.37e-11 | 46 | 69 | 7 | CID000108062 | |
| Drug | ridogrel | 2.06e-10 | 52 | 69 | 7 | CID005362391 | |
| Drug | NSC49633 | 2.37e-10 | 53 | 69 | 7 | CID000023340 | |
| Drug | 4-hydroxyproline | 3.26e-10 | 91 | 69 | 8 | CID000000825 | |
| Drug | hydroxylysine | 1.40e-09 | 109 | 69 | 8 | CID000001029 | |
| Drug | malotilate | 1.96e-09 | 71 | 69 | 7 | CID000004006 | |
| Drug | AC1L9732 | 2.00e-09 | 114 | 69 | 8 | CID000439300 | |
| Drug | AC1NMZ1B | 2.90e-09 | 75 | 69 | 7 | CID005034185 | |
| Drug | strontium ranelate | 3.49e-09 | 77 | 69 | 7 | CID006918182 | |
| Drug | foscarnet | COL3A1 CACNA1B COL24A1 COL9A2 COL10A1 COL17A1 COL22A1 BSN COL1A2 | 5.98e-09 | 190 | 69 | 9 | CID000003414 |
| Drug | DMSe | 6.40e-09 | 132 | 69 | 8 | CID000020796 | |
| Drug | halofuginone lactate | 7.03e-09 | 85 | 69 | 7 | CID000062891 | |
| Drug | pirfenidone | 9.09e-09 | 138 | 69 | 8 | CID000040632 | |
| Drug | colchine | COL3A1 BOC COL24A1 COL9A2 COL10A1 COL17A1 COL22A1 MMP1 BSN MEFV COL1A2 | 2.01e-08 | 383 | 69 | 11 | CID000002833 |
| Drug | ticlopidine | 2.70e-08 | 103 | 69 | 7 | CID000005472 | |
| Drug | AC1L1C2F | 4.27e-08 | 110 | 69 | 7 | CID000001711 | |
| Drug | khellin | 4.86e-08 | 171 | 69 | 8 | CID000003828 | |
| Drug | PPACK | 5.15e-08 | 113 | 69 | 7 | CID003036757 | |
| Drug | Tranilast sodium | 5.81e-08 | 115 | 69 | 7 | CID000005527 | |
| Drug | prostacyclin sodium salt | COL3A1 BOC COL24A1 COL9A2 COL10A1 COL17A1 COL22A1 TBX2 COL1A2 | 6.42e-08 | 250 | 69 | 9 | CID000000159 |
| Drug | AC1L1DD6 | 6.93e-08 | 179 | 69 | 8 | CID000002299 | |
| Drug | hyaluronan | COL3A1 COL24A1 COL9A2 COL10A1 COL17A1 RTN4R COL22A1 MMP1 COL1A2 | 9.89e-08 | 263 | 69 | 9 | CID000024759 |
| Drug | Selara | 1.03e-07 | 125 | 69 | 7 | CID000150310 | |
| Drug | DL-penicillamine | 2.14e-07 | 139 | 69 | 7 | CID000004727 | |
| Drug | PCR 4099 | 2.14e-07 | 139 | 69 | 7 | CID000002806 | |
| Drug | candesartan cilexetil | 2.85e-07 | 145 | 69 | 7 | CID000002540 | |
| Drug | (2s,5s)-5-Carboxymethylproline | COL3A1 COL24A1 COL9A2 COL10A1 COL17A1 RRP1B COL22A1 MMP1 COL1A2 | 4.41e-07 | 314 | 69 | 9 | CID000447989 |
| Drug | AC1L18QD | COL3A1 CACNA1B COL24A1 COL9A2 COL10A1 COL17A1 COL22A1 TBX2 COL1A2 | 5.89e-07 | 325 | 69 | 9 | CID000000213 |
| Drug | L-lysyl-L-lysyl-L-lysine | 6.04e-07 | 162 | 69 | 7 | CID000072363 | |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | 1.70e-06 | 189 | 69 | 7 | CID000001413 | |
| Drug | chondroitin sulfate | COL3A1 COL24A1 COL9A2 COL10A1 COL17A1 RTN4R COL22A1 MMP1 COL1A2 | 4.22e-06 | 413 | 69 | 9 | CID000024766 |
| Drug | AC1Q6PCP | 6.21e-06 | 230 | 69 | 7 | CID000005267 | |
| Drug | pyridinoline | 1.27e-05 | 99 | 69 | 5 | CID000105068 | |
| Drug | losartan | 1.85e-05 | 378 | 69 | 8 | CID000003961 | |
| Drug | silibinin | 2.49e-05 | 285 | 69 | 7 | CID000005213 | |
| Drug | 1h00 | 2.52e-05 | 56 | 69 | 4 | CID000445950 | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.96e-05 | 197 | 69 | 6 | 5207_UP | |
| Drug | Collagenase | 5.41e-05 | 4 | 69 | 2 | DB00048 | |
| Drug | DIBADL | 5.41e-05 | 4 | 69 | 2 | CID000194129 | |
| Drug | L-3,4-dehydroproline | 7.18e-05 | 73 | 69 | 4 | CID000094284 | |
| Drug | AC1L1KMJ | 9.41e-05 | 476 | 69 | 8 | CID000030956 | |
| Drug | Diphosphonates | 1.35e-04 | 6 | 69 | 2 | ctd:D004164 | |
| Drug | 2-phenyl-4-(3-pyridin-2-yl-1H-pyrazol-4-yl)pyridine | 1.35e-04 | 6 | 69 | 2 | ctd:C502971 | |
| Drug | isodesmosine | 1.36e-04 | 33 | 69 | 3 | CID000013811 | |
| Drug | LMWH | COL3A1 BOC COL24A1 COL9A2 COL10A1 COL17A1 COL22A1 MMP1 COL1A2 | 1.70e-04 | 663 | 69 | 9 | CID000000772 |
| Drug | benzotrichloride | 1.88e-04 | 7 | 69 | 2 | CID000007367 | |
| Drug | neo-gambogic acid | 1.88e-04 | 7 | 69 | 2 | ctd:C045863 | |
| Drug | hydroxyallysine | 2.50e-04 | 8 | 69 | 2 | CID000153008 | |
| Drug | CP-23 | 2.50e-04 | 8 | 69 | 2 | CID000452645 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 9.31e-07 | 9 | 67 | 3 | DOID:13359 (is_implicated_in) | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 6.54e-06 | 53 | 67 | 4 | C4707243 | |
| Disease | skin disease (implicated_via_orthology) | 1.52e-05 | 3 | 67 | 2 | DOID:37 (implicated_via_orthology) | |
| Disease | reticulon-4 receptor measurement | 3.04e-05 | 4 | 67 | 2 | EFO_0020705 | |
| Disease | Ehlers-Danlos Syndrome | 5.06e-05 | 5 | 67 | 2 | C0013720 | |
| Disease | Ehlers-Danlos syndrome | 1.41e-04 | 8 | 67 | 2 | cv:C0013720 | |
| Disease | glomerulosclerosis (biomarker_via_orthology) | 2.26e-04 | 10 | 67 | 2 | DOID:0050851 (biomarker_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 3.30e-04 | 12 | 67 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | atherosclerosis (is_implicated_in) | 5.97e-04 | 16 | 67 | 2 | DOID:1936 (is_implicated_in) | |
| Disease | hypertension | 6.73e-04 | 307 | 67 | 5 | EFO_0000537 | |
| Disease | asparaginase hypersensitivity | 7.26e-04 | 77 | 67 | 3 | EFO_0004881 | |
| Disease | Oral Submucous Fibrosis | 7.59e-04 | 18 | 67 | 2 | C0029172 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 8.47e-04 | 19 | 67 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | hippuric acid measurement | 8.47e-04 | 19 | 67 | 2 | EFO_0010496 | |
| Disease | Liver Cirrhosis | 1.68e-03 | 103 | 67 | 3 | C0023890 | |
| Disease | glucose measurement | 1.73e-03 | 380 | 67 | 5 | EFO_0004468 | |
| Disease | Fibrosis, Liver | 1.78e-03 | 105 | 67 | 3 | C0239946 | |
| Disease | Early Pregnancy Loss | 1.98e-03 | 109 | 67 | 3 | C3830362 | |
| Disease | Miscarriage | 1.98e-03 | 109 | 67 | 3 | C4552766 | |
| Disease | Spontaneous abortion | 1.98e-03 | 109 | 67 | 3 | C0000786 | |
| Disease | Abortion, Tubal | 1.98e-03 | 109 | 67 | 3 | C0000822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PRREAPGNGGHSAGP | 41 | Q6NS38 | |
| AMGPAGPDGHQGPRG | 741 | Q9UMD9 | |
| GQGDPGPAAGHHAQP | 1131 | O94986 | |
| SPGDGHNAPVEGPEG | 226 | Q8TER5 | |
| DRPLGGGEGHQPAGN | 21 | Q00994 | |
| PPGHGQTLGQQVPGF | 481 | P46379 | |
| ASSVGGPNGGKQHPP | 241 | P54259 | |
| PKRQENPGHPGGAGG | 631 | Q7Z5R6 | |
| PGHVGQMGPVGAPGR | 201 | P08572 | |
| DRGDPGQHGLPGFPG | 516 | P08572 | |
| GPIGHQGPIGQEGAP | 1456 | P08572 | |
| AGPGEGPAADPLHQA | 31 | Q92843 | |
| GGPGQGESKQPRPDH | 211 | P18089 | |
| GLPGHNGLDGQPGPQ | 151 | Q6ZMI3 | |
| IAGNPQPVHGAGPGS | 201 | P33240 | |
| QEPGPHPQGSGSVNG | 2156 | Q00975 | |
| GGVGNGHPNRLDPIP | 1071 | Q8NB25 | |
| SHGGPPQGAVPQSGV | 996 | Q8WWM7 | |
| HPQGEQPGQAPGFPG | 1026 | Q8WWM7 | |
| QPGGLGPALHQFPAG | 606 | Q8HWS3 | |
| GVHPAPGFPGGVSQQ | 11 | Q5VVQ6 | |
| RQPQPDGGDAPGHEP | 6 | Q13469 | |
| DGALGQRGPPEPAGH | 831 | Q02779 | |
| PSFHLGGPAVGPRGN | 361 | P43243 | |
| AAGPLNGDHPGPGQS | 346 | Q9HCH0 | |
| QPNFPGGNDGHHRPL | 61 | Q8NDZ0 | |
| QQGQAAGARGPHGGP | 1201 | Q9UPA5 | |
| EGGPAPGTAQQPRVH | 1141 | Q8ND23 | |
| QLPGGPHAPNGACLG | 2786 | Q7Z7M0 | |
| PDHPEGNEGNGPRPY | 121 | O15553 | |
| VQGEDGPGSQPGTHP | 136 | P41271 | |
| EHPGARGAGGGRQQP | 21 | O15504 | |
| SALPARGHGQEPGGP | 71 | P09016 | |
| PPGIPGNHGNNGNNG | 61 | Q9BXJ4 | |
| DTCRQGHPGIPGNPG | 21 | P0C862 | |
| PGNPGHNGLPGRDGR | 31 | P0C862 | |
| RAQAAGQGPGQGPGP | 71 | Q9UP38 | |
| GNDGPPGRDGQPGHK | 931 | P08123 | |
| PAGIRGPQGHQGPAG | 1076 | P08123 | |
| VPLGGLPGHQASGQP | 906 | Q9BWV1 | |
| GLPGLQGHPGHQGIP | 1111 | Q9P218 | |
| PLHPGSNQGAPRQGG | 106 | H7C350 | |
| QPGSPGHQGLAGVPG | 326 | Q14055 | |
| DTCRQGHPGIPGNPG | 21 | B2RNN3 | |
| PGNPGHNGLPGRDGR | 31 | B2RNN3 | |
| QFGGQRGPPPGHFVG | 1911 | Q9BTC0 | |
| RLGPQGAPGQRGAHG | 346 | P05997 | |
| KGEQGAPGPRGHQGA | 656 | Q8NFW1 | |
| APEQGPAQAAGHPSG | 356 | Q9P2E8 | |
| SPGPPQVEEVGHRGG | 36 | P12980 | |
| HRRPPDPEGAGGAAG | 26 | Q8TD94 | |
| GQRGEPGPQGHAGAQ | 366 | P02461 | |
| TPCGPHQGQDEGRGP | 381 | Q6SPF0 | |
| HQGQDEGRGPAPGSG | 386 | Q6SPF0 | |
| PAGPGAGPAPHQQNG | 31 | O95487 | |
| GAEGPQGPRGLQGPH | 506 | P25940 | |
| EPGPPGQQGNHGSQG | 636 | P25940 | |
| PGHQGKDGRPGHPGQ | 886 | P25940 | |
| HPPGQDDGGGDHEPV | 11 | Q9UBU6 | |
| GDSPPGNGSGPRHIN | 366 | Q9BZR6 | |
| HPQGPRGSPTGGAQL | 506 | Q14684 | |
| APDGQGPGPQAAREH | 611 | Q9BZL4 | |
| GQDSLGPPEHFQGGP | 51 | Q8N205 | |
| GPPEHFQGGPRGNEP | 56 | Q8N205 | |
| FQGGPRGNEPAAHPP | 61 | Q8N205 | |
| GPGGNLAHAFQPGPG | 176 | P03956 | |
| GMPGHNGEAGPRGAP | 431 | Q03692 | |
| YRGHQGQPGPSGLPG | 1171 | Q17RW2 | |
| PPAEGGHPGAAQRGQ | 386 | Q8NFZ5 | |
| QPGPGADHPQAGAPG | 71 | Q8TDR2 | |
| HGARGGQPPVPQQHV | 96 | Q8IXZ2 | |
| PAPAAHVAGNPGGDA | 46 | P16989 | |
| GPVQGGPQPSGQHRS | 216 | O15027 | |
| GPLGAGQPLFLHPGQ | 481 | Q13207 | |
| QNPALSPAHGGAGPA | 881 | Q9P2F5 | |
| SGEPPAGGAQEPAHA | 221 | Q6N022 | |
| GHSSPQIRQGGVPGP | 1051 | Q2M1Z3 | |
| EQPVGGTDPPAHGGR | 136 | Q6ZS52 | |
| DGPGVPAQASDHGLP | 61 | Q8N1G0 | |
| GPVGPHRMQNGFGSP | 116 | Q8N1G0 | |
| GPGPNKGDSRGPPNH | 951 | Q9C0J8 | |
| PSQGAPGHGRAGLPE | 151 | Q6ZS46 | |
| QTPHEDGGPQPHRGG | 441 | Q9BRZ2 | |
| NGPVHGMGPAGGFPN | 401 | Q9Y493 |